ArticleSurgical endoscopy2025
Mid-term outcomes of the patients of achalasia cardia undergoing laparoscopic Heller's myotomy with angle of his accentuation versus laparoscopic Heller's myotomy with Toupet's fundoplication.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe choice of anti-reflux procedure with Laparoscopic Heller's myotomy (LHM) is debatable. LHM with Dor's fundoplication is the most common procedure performed and has shown similar outcomes to LHM with Toupet's fundoplication and LHM with Angle of His accentuation (AOH). The present study describes the mid-term outcomes comparing LHM with AOH and LHM with Toupet's fundoplication.
methodsEighty-six patients who underwent LHM-AOH (group A, n = 43), versus LHM-Toupet's fundoplication (group B, n = 43) for achalasia cardia were followed up for symptomatic improvement (Eckardt score, ES ≤ 3), improvement in Achalasia disease specific health related quality of life (ADsQoL) and clinical reflux (DeMeester's heartburn score ≥ 2, and esophagitis on endoscopy).
resultsAt a median duration of 52.5 (IQR 34-67) months, mean ES in both groups decreased (7.42 to 1.2, p < 0.00001, group A and 7.37 to 1.23, p < 0.00001, group B) with no difference among the two groups. Mean ADsQoL scores decreased in both groups significantly (23.3 to 13.7, p < 0.00001, group A and 23.2 to 13.3, p < 0.00001, group B) with the mean ADsQoL scores at the last follow-up being statistically similar in both the groups (p = 0.93). Clinically significant heartburn was seen in 5 (11.6%) and 7 (16.3%) patients in group A and B, respectively (p = 0.76). Ninety-one and 95% patients in group A and B, respectively, had good to excellent satisfaction. Follow-up UGIE (median: 12 months) could be performed in 33 (group A) and 28 patients (group B), with 9 (27%) patients in group A and 4 (14.3%) patients in group B showing LA-A or B esophagitis (p = 0.22). No patient had LA-C/D esophagitis. Frequent use of proton pump inhibitors was there by 5 patients in each group (11.6%).
conclusionLHM-AOH and LHM-Toupet's fundoplication are comparable with respect to symptomatic relief, improvement in quality of life and clinical reflux rates.
Indexed as
Identifiers
40562957What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.